Rapid Protein Expression and Purification


Therapeutic recombinant protein drugs expressed in mammalian cells are closer to human natural protein in structure and function. Based on this, we launched the rapid protein preparation service. We have accumulated rich experience in protein preparation. It has successfully completed tens of thousands of protein preparations, covering various molecular types such as nanobodies, human or humanized IgG antibodies, cytokines and other types of recombinant proteins.

Service Highlights

1. Mammalian cell expression system, close to natural proteins

  • In our rapid protein expression and purification services, mammalian cell expression system (CHO/HEK293) is used, and the recombinant protein obtained by the system has a biological active conformation similar to the natural proteins.

2. Multi-dimensional quality control system ensuring high quality

  • The quality of the antigen and antibody proteins could be evaluated by multiple parameters, such as concentration, purity, molecular weight, aggregation, stability, safety, charge heterogeneity, sequence variant, structure analysis and binding or blocking bioactivity analysis.

3. Efficient delivery enabling the completion within 2 weeks

  • It is an integrated service that includes plasmid construction, extraction, transient expression, protein purification and protein quality control, the whole process of which could be completed as fast as 2 weeks.

4. Personalized services providing flexible choices

  • With 3 eukaryotic expression systems, several expression volumes, 2 transient methods, 2 purification tags and 8 quality control indexes provided, customers could obtain a high-precision customization based on the specific needs of the project by combining those five dimensions flexibly.



Popular articles

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more
Shanghai Model Organisms Jinshan R&D Base officially put into operation

After the base is put into operation, SMOC’s capability to provide genetically modified rat/mouse models and technical services including gene function research and drug development will be greatly enhanced.

Learn more